v3.26.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 515,114 $ 547,306 $ 579,371
Cost of sales (367,553) (426,989) (400,207)
Gross profit 147,561 120,317 179,164
Operating expenses      
Selling, general and administrative (110,633) (119,634) (116,887)
Research, product development and regulatory (23,161) (32,662) (38,025)
Product liability claims (9,730) 0 0
Transformation (7,187) (20,162) (957)
Asset impairment (25,395) (50,414) 0
Gain from sale of assets 249 1,000 0
Operating (loss) income (28,296) (101,555) 23,295
Change in fair value of equity investments, net (437) (2,356) (359)
Interest and other interest expenses, net (18,470) (16,547) (12,639)
(Loss) income before provision for income taxes (47,203) (120,458) 10,297
Provision for income taxes (2,679) (5,882) (2,778)
Net (loss) income $ (49,882) $ (126,340) $ 7,519
(Losses) earnings per common share—basic $ (1.75) $ (4.5) $ 0.27
(Losses) earnings per common share—assuming dilution $ (1.75) $ (4.5) $ 0.26
Weighted average shares outstanding—basic 28,426 28,059 28,128
Weighted average shares outstanding—assuming dilution 28,426 28,059 28,533